Updated AESI List for Marburg Virus Disease Now Available
December 2, 2025
The SPEAC Project has released an updated list of Adverse Events of Special Interest (AESI) for Marburg virus disease (MVD) vaccines, v2.1. This update
The SPEAC Project has released an updated list of Adverse Events of Special Interest (AESI) for Marburg virus disease (MVD) vaccines, v2.1. This update
The SPEAC Project has released an updated list of Adverse Events of Special Interest (AESI) for Rift Valley fever (RVF) vaccines. This update reflects the
The International Society of Pharmacovigilance (ISOP) 2025 Annual Meeting in Cairo will feature multiple presentations from the Safety Platform for Emergency vACcines (SPEAC), funded by
Earlier this month, members of the Brighton Collaboration’s Safety Platform for Emergency vACcines (SPEAC) Executive Board and Work Package leads convened in person at the
At the 19th Vaccine Congress in Kyoto, Dr. Robert Chen, Project Lead of the Safety Platform for Emergency Vaccines (SPEAC), presented a poster reflecting on
When it comes to vaccine safety, precision matters. That’s why the Brighton Collaboration and SPEAC have created Case Definition Companion Guides—practical tools designed to ensure
The Safety Platform for Emergency vACcines (SPEAC) is a project funded by the Coalition for Epidemic Preparedness Innovations (CEPI). SPEAC is located at Brighton Collaboration, a program of the Task Force for Global Health.
© SPEAC 2023. All rights reserved.